Literature DB >> 3322629

Pharmacotherapy in bronchopulmonary dysplasia.

P W Blanchard1, T M Brown, A L Coates.   

Abstract

This article reviews the current data available on the most frequently used drugs in bronchopulmonary dysplasia. Oxygen, diuretics, bronchodilators, steroids, ribavirin, and antioxidants, as well as medication available for pulmonary hypertension, systemic hypertension, and gastroesophageal reflux are discussed, with emphasis on known advantages, side effects, and current dosage.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3322629

Source DB:  PubMed          Journal:  Clin Perinatol        ISSN: 0095-5108            Impact factor:   3.430


  2 in total

1.  Pulmonary function changes after nebulised and intravenous frusemide in ventilated premature infants.

Authors:  V G Prabhu; M Keszler; R Dhanireddy
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-07       Impact factor: 5.747

Review 2.  Drug utilisation in preterm and term neonates.

Authors:  L Gortner
Journal:  Pharmacoeconomics       Date:  1993-12       Impact factor: 4.981

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.